0001209191-20-024484.txt : 20200415
0001209191-20-024484.hdr.sgml : 20200415
20200415164154
ACCESSION NUMBER: 0001209191-20-024484
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200409
FILED AS OF DATE: 20200415
DATE AS OF CHANGE: 20200415
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Basenese Lou
CENTRAL INDEX KEY: 0001809482
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37969
FILM NUMBER: 20794147
MAIL ADDRESS:
STREET 1: 3600 GREEN COURT, SUITE 350
CITY: ANN ARBOR
STATE: MI
ZIP: 48105
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ENDRA Life Sciences Inc.
CENTRAL INDEX KEY: 0001681682
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 260579295
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3600 GREEN COURT
STREET 2: SUITE 350
CITY: ANN ARBOR
STATE: MI
ZIP: 48105
BUSINESS PHONE: 734-335-0468
MAIL ADDRESS:
STREET 1: 3600 GREEN COURT
STREET 2: SUITE 350
CITY: ANN ARBOR
STATE: MI
ZIP: 48105
FORMER COMPANY:
FORMER CONFORMED NAME: Endra Inc.
DATE OF NAME CHANGE: 20160805
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-04-09
0
0001681682
ENDRA Life Sciences Inc.
NDRA
0001809482
Basenese Lou
3600 GREEN COURT, SUITE 350
ANN ARBOR
MI
48105
1
0
0
0
Common Stock
2020-04-09
4
A
0
41587
0.00
A
41587
D
Stock Option (right to buy)
0.70
2020-04-09
4
A
0
50000
0.00
A
2030-04-09
Common Stock
50000
50000
D
Represents restricted stock units granted in lieu of the Reporting Person's cash retainer payable under the Issuer's Non-Employee Director Compensation Policy for the second, third and fourth quarters of 2020. The restricted stock units vest in three equal installments on the last day of each such calendar quarter. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
Includes unvested restricted stock units.
Represents a stock option award granted on April 9, 2020 pursuant to the Issuer's Non-Employee Director Compensation Policy.
This stock option grant becomes exercisable in three equal annual installments beginning April 9, 2021.
/s/ Louis J. Basenese by Mark Busch, attorney-in-fact
2020-04-15